Autel U.S. Training Event Introduces a New Approach to Automotive HVAC Diagnostics
Automotive HVAC is no longer limited to maintaining cabin comfort. In hybrid and electric vehicles—and increasingly in internal combustion engine vehicles—thermal management systems regulate the temperatures of batteries, power electronics, computers and other components essential to vehicle performance and operation.
Despite this expanding responsibility, automotive A/C diagnosis remains largely centered on refrigerant service and the interpretation of high- and low-side pressures. The AC909 was designed to give technicians a more complete view of system operation by combining live vehicle data with refrigerant pressures, temperatures, humidity, airflow, electrical and sensor measurements on a single graphical analysis screen.
Guided procedures help technicians evaluate system operation, diagnose components, identify the cause of poor performance and verify repairs. This approach represents a significant shift in how technicians diagnose and service vehicle HVAC systems.
"The response to the AC909 has confirmed what we believed from the beginning: technicians have been waiting for a better way to diagnose these systems," DeLuca said. "HVAC now plays a much greater role in overall vehicle performance, but the diagnostic process has not kept pace. This training will help technicians understand why automotive HVAC diagnosis must evolve along with the vehicle and why the AC909 represents a new paradigm for the industry."
Led by DeLuca and Applied Automotive Technology owner
The training will run from
To register, visit autel.cc/hvac-training-ny. To learn more about the AC909D, visit autel.us/product/maxihvac-ac909/.
Press inquiries: Allison Whitney, [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/autel-us-training-event-introduces-a-new-approach-to-automotive-hvac-diagnostics-302889335.html
SOURCE Autel
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer
- MIMS Accelerates Product Innovation and International Growth
- Hyperliquid Price Prediction After Binance Listing: HYPE Nears $95 While Pepeto Presale Builds a 100x Case
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share